CHRONIC HEART FAILURE TODAY: A LITERATURE REVIEW
Keywords:
chronic heart failure, ejection fraction, pathogenesis, treatment, diagnostics, SGLT2, ACE inhibitors, mortality.Abstract
The article focuses on the current classification of CHF by left ventricular ejection fraction (HFrEF, HFmrEF, HFpEF) and NYHA functional classes. Current approaches to diagnostics, including the use of biomarkers and imaging methods, are covered. Current drug treatment strategies, including the use of RAAS inhibitors, beta-blockers, aldosterone antagonists, and SGLT2 inhibitors, are considered in detail. New areas of therapy and five-year mortality data are also presented. The article includes tables and diagrams illustrating the epidemiological and clinical aspects of CHF. The review emphasizes the need for a multidisciplinary approach and further research in the field of personalized therapy.
References
Armstrong P.W. et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. NEJM. 2022.
Bozkurt B. et al. Universal Definition and Classification of Heart Failure. JACC. 2021.
Gheorghiade M. et al. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013.
Komajda M. et al. Heart failure with preserved ejection fraction: a multifactorial syndrome. Eur Heart J. 2016.
McDonagh T.A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021.
Metra M. & Teerlink J.R. Heart failure. Lancet. 2017.
Packer M. et al. Effect of empagliflozin in patients with heart failure. NEJM. 2021.
Pitt B. et al. The role of mineralocorticoid receptor antagonists in cardiovascular disease. Eur Heart J. 2018.
Ponikowski P. et al. Heart failure: preventing disease and death worldwide. ESC White Paper. 2020.
Savarese G. & Lund L.H. Global public health burden of heart failure. Card Fail Rev. 2017.
Swedberg K. et al. Guidelines on diagnosis and treatment of CHF. Eur Heart J. 2005.
Vaduganathan M. et al. Sodium-glucose co-transporter 2 inhibitors in heart failure: State of the art. Eur Heart J. 2020.
Yancy C.W. et al. 2017 ACC/AHA/HFSA Guideline Update for the Management of Heart Failure. Circulation. 2017.
